Home Tags Rare Diseases

Rare Diseases Related News

Concomitant use of benzodiazepine drugs common amongst AD patients

Concomitant use of benzodiazepine drugs common amongst AD patients

The most commonly concomitant use amongst AD patients was benzodiazepine drugs and a weak opioid – where one in five people with Alzheimer’s disease...
Have researchers found a way to fight muscular paralysis?

Have researchers found a way to fight muscular paralysis?

Myotubular myopathy is a severely genetic disease leading to muscular paralysis and even results in death at a young age, however researchers may have...
Health Europa Quarterly Issue 07: explore the world of health and medicine

Health Europa Quarterly Issue 07: explore the world of health and medicine

Editor Kathryn Washburn introduces the seventh edition of Health Europa Quarterly, focusing on sustainable healthcare, medical cannabis, drug development and neurological disorders, among other...
Reference networks and research for rare diseases

Reference networks and research for rare diseases

Health Europa looks at the diagnosis and treatment of rare diseases and related research efforts. Focusing on the European Reference Networks and the New...
Hypotrichosis simplex: Researchers uncover new hair loss genes

Hypotrichosis simplex: Researchers uncover new hair loss genes

Hypotrichosis simplex leads to gradual hair loss in childhood and researchers have deciphered new hair loss genes responsible for this rare form of hair...
Mucopolysaccharide storage diseases and puberty and adolescence

Mucopolysaccharide storage diseases and puberty and adolescence

The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
The Fool’s Tower: Europe’s oldest building that accommodated mental patients

The Fool’s Tower: Europe’s oldest accommodation for mental patients

Health Europa explores with those involved in managing and expanding the then-hospital for mental patients, Vienna’s Narrenturm (Fool’s Tower). In September, Health Europa travelled to...
The Swiss perspective on mucopolysaccharide disease

The Swiss perspective on mucopolysaccharide disease

Dr Fredi Wiesbauer, vice president of the Swiss Mucopolysaccharide disease (MPS) Society met with Health Europa and explored the Swiss experience of hosting such...
What do you know about Zellweger spectrum disorders?

What do you know about Zellweger spectrum disorders?

Zellweger UK explains how the charity is working to support research into Zellweger spectrum disorders. The Zellweger Spectrum Disorders (ZSD) comprise a group of genetic...
Diagnostic tools and therapies to be developed by new Horizon 2020 projects

Diagnostic tools and therapies to be developed by new Horizon 2020 projects

New Horizon 2020 projects set to collaboratively research and develop innovative diagnostic tools and therapies for rare diseases. Almost a dozen new collaborative research and...
Orion Corporation to provide better personalised treatments through ecosystem development

Orion Corporation to provide better personalised treatments through ecosystem development

Orion Corporation has come together with selected university research groups and companies to develop better personalised treatments using a New Modalities Ecosystem. Funded by Business...
Could the puzzle around fatal blood diseases be uncovered

Could the puzzle around fatal blood diseases be uncovered?

Scientists are closer to uncovering the mystery surrounding a group of fatal blood diseases known as myelodysplastic syndromes (MDS). According to Cincinnati Children's Hospital Medical Centre,...
The Austrian MPS Society’s Therapy Week – more than just therapy

The Austrian MPS Society’s Therapy Week – more than just therapy

In July, Health Europa saw first-hand how the Austrian MPS Society’s Therapy Week brings patients and their families together for more than just a...
How is MPS Austria improving understanding of mucopolysaccharidoses?

How is MPS Austria improving understanding of mucopolysaccharidoses?

Professor Dr Dr Susanne Gerit Kircher discusses her work alongside the Austrian MPS Society towards a better understanding of mucopolysaccharidoses. Speaking to Health Europa during...
Make Patients Smile: the MPS Austria Therapy Week mission

Make Patients Smile: the MPS Austria Therapy Week mission

Continuing its coverage of the MPS Austria Therapy Week, Health Europa speaks to childcare organiser Anna Prähofer about how the event has evolved since...
Connecting patients with a rare digestive disorder to research and cures

Connecting patients with a rare digestive disorder to research and cures

Life with a rare digestive disorder often means suffering with disabling symptoms for years before receiving the correct diagnosis and appropriate care. Patient advocacy...

The Matchmaker Exchange connects researchers and clinicians to identify novel Mendelian disease genes

The Matchmaker Exchange (MME) was initiated in October 2013 as a community-organized effort to connect clinicians and researchers with rare cases. Matchmakers had evolved...
MPS Society

The MPS Society: supporting those with mucopolysaccharidoses

Being diagnosed and living with mucopolysaccharidoses is life changing. The Austrian MPS Society, MPS Austria, is an organisation which supports families and their individuals...
MPS diseases

Key areas of research in the diagnosis and treatment of MPS diseases

Professor Dr François Eyskens of PCMA vzw discusses early diagnosis of MPS diseases by creating awareness and using a tandem mass spectrometry screening method. MPS...
Diagnosing mucopolysaccharidoses diseases in young people

Diagnosing mucopolysaccharidoses diseases in young people

This booklet was written by Professor Dr Francois Eyskens of the PCMA vzw, the metabolic laboratory, and the Center of Inherited Metabolic Diseases at...

Pin It on Pinterest